Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Laboratory“
Suchtreffer
Begriffe & Kennungen
Braftovi · 4.8 · In Study CMEK162B2301-Part 2, in the Combo 300 arm, the incidence of liver laboratory abnormalities was: • Inc
Eintrag öffnenBraftovi · 4.8 · Liver laboratory abnormality Melanoma and NSCLC The incidences of liver laboratory abnormalities reported in t
Eintrag öffnenBridion · 4.5 · Interference with laboratory tests: In general sugammadex does not interfere with laboratory tests, with the p
Eintrag öffnenBriumvi · 4.8 · Laboratory abnormalities
Eintrag öffnenBrukinsa · 4.8 · 37 † Based on laboratory measurements. § Includes multiple adverse reaction terms. # Includes events with fata
Eintrag öffnenBrukinsa · 4.8 · CTCAE) version 4.03. † Based on laboratory measurements. ± Percentages are based on number of patients with bo
Eintrag öffnenBrukinsa · 4.8 · CTCAE) version 4.03. † Based on laboratory measurements. ± Percentages are based on number of patients with bo
Eintrag öffnenBrukinsa · 4.8 · Platelet count decreased† (based on laboratory values) was observed in 65% (all grade) and 12% (grade 3 or 4)
Eintrag öffnenBrukinsa · 4.8 · Platelet count decreased† (based on laboratory values) was observed in 65% (all grade) and 12% (grade 3 or 4)
Eintrag öffnenBrukinsa · 4.8 · version 5.0.) † Based on laboratory measurements. § Includes multiple adverse reaction terms. # Includes event
Eintrag öffnenCabazitaxel Accord · 4.8 · Other laboratory abnormalities In pooled analysis, the incidence of grade ≥3 anaemia, increased AST, ALT, and
Eintrag öffnenCancidas (previously Caspofungin MSD) · 4.8 · Reported clinical and laboratory abnormalities among all adults treated with caspofungin (total 1,780) were ty
Eintrag öffnenCelsentri · 4.8 · In treatment-naïve patients, the incidence of grade 3 and 4 laboratory abnormalities using ACTG criteria was s
Eintrag öffnenCelsentri · 4.8 · In treatment-naïve patients, the incidence of grade 3 and 4 laboratory abnormalities using ACTG criteria was s
Eintrag öffnenCelsentri · 4.8 · Laboratory abnormalities
Eintrag öffnenCelsentri · 4.8 · Laboratory abnormalities
Eintrag öffnenCelsentri · 4.8 · Maraviroc 300 mg Placebo + OBT Laboratory parameter Limit twice daily + OBT N =207* N =421* (%) (%) Hepatobili
Eintrag öffnenCelsentri · 4.8 · Maraviroc 300 mg Placebo + OBT Laboratory parameter Limit twice daily + OBT N =207* N =421* (%) (%) Hepatobili
Eintrag öffnenCelsentri · 4.8 · Table 4: Incidence ≥1% of grade 3-4 abnormalities (ACTG criteria) based on maximum shift in laboratory test va
Eintrag öffnenCelsentri · 4.8 · Table 4: Incidence ≥1% of grade 3-4 abnormalities (ACTG criteria) based on maximum shift in laboratory test va
Eintrag öffnen